Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer

Journal of Pediatric Urology

Volumn 4, Issue 3, 2008, Pages 221-228

  Molitierno, Joseph A ^a   Scherz, Hal C ^a   Kirsch, Andrew J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deflux; Dextranomer hyaluronic acid copolymer; Endoscopic treatment; Vesicoureteral reflux

Indexed keywords

ANTIBIOTIC AGENT; DEXTRANOMER HYALURONIC ACID COPOLYMER; HYALURONIC ACID DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; ANTIREFLUX OPERATION; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DIVERTICULOSIS; ECTOPIC URETER; ENDOSCOPIC THERAPY; FEVER; HUMAN; MEGAURETER; MICTURITION DISORDER; MORBIDITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION; TREND STUDY; URETER MALFORMATION; URETER REIMPLANTATION; URINARY TRACT INFECTION; VESICOURETERAL REFLUX;

CHILD; CYSTOSCOPY; DEXTRANS; HUMANS; HYALURONIC ACID; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME; VESICO-URETERAL REFLUX;

EID: 44649131448     PISSN: 14775131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpurol.2007.11.015     Document Type: Article

References (39)

1. Smellie J., Edwards D., Hunter N., Normand I.C., and Prescod N. Vesico-ureteric reflux and renal scarring. Kidney Int Suppl 4 (1975 Aug) S65-S72
2. Bailey R. Vesicoureteric reflux in healthy infants and children. In: Hodson J., and Kincaid-Smith P. (Eds). Reflux nephropathy (1979), Masson Publishing, New York 59-61
3. Jacobson S.H., Hansson S., and Jakobsson B. Vesico-ureteric reflux: occurrence and long-term risks. Acta Paediatr 88 (1999) 22-30
4. Lendvay T.S., Sorensen M., Cowan C.A., Joyner B.D., Mitchell M.M., and Grady R.W. The evolution of vesicoureteral reflux management in the era of dextranomer/hyaluronic acid copolymer: a pediatric health information system database study. J Urol 176 (2006) 1864-1867
5. Stenberg A., and Lackgren G. Treatment of vesicoureteral reflux in children using stabilized non-animal hyaluronic acid/dextranomer gel (NASHA/DX): a long-term observational study. J Pediatr Urol 3 (2007) 80-85
6. Ogan K., Pohl H., Carlson D., Belman B., and Rushton G. Parental preferences in the management of vesicoureteral reflux. J Urol 166 (2001) 240
7. Capozza N., Lais A., Matarazzo E., Nappo S., Patricolo M., and Caione P. Treatment of vesico-ureteric reflux: a new algorithm based on parental preference. BJU Int 92 (2003) 285-288
8. Hensle TW, Hyun G, Grogg A, Eaddy M. Examining pediatric vesicoureteral reflux: a real-world evaluation of treatment patterns and outcomes. American Urological Association Annual Meeting, 20-25 May 2006, Atlanta, Georgia [abstract 761].
9. Molitierno JA, Watson JM, Scherz HC, Kirsch AJ. Paradigm shift in the surgical management of vesicoureteral reflux: 21st century treatment of a 20th century problem. American Urological Association Annual Meeting, 19-24 May 2007, Anaheim, California [abstract 60].
10. Matouschek E. New concept for the treatment of vesico-ureteral reflux. Endoscopic application of Teflon. Arch Esp Urol 34 (1981) 385
11. Puri P., Ninan G.K., and Surana R. Subureteric Teflon injection (STING). Results from a European Survey. Eur Urol 27 (1995) 71
12. Lackgren G., Wahlin N., Skoldenberg E., and Stenberg A. Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166 (2001) 1887
13. Lackgren G., Wahlin N., Skoldenberg E., Neveus T., and Stenberg A. Endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer is effective in either double ureters or a small kidney. J Urol 170 (2003) 1551-1555
14. Kirsch A.J., Perez-Brayfield M., Smith E.A., and Scherz H.C. The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171 6 Pt 1 (2004 Jun) 2413-2416
15. Yu R.N., and Roth D.R. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon. Pediatrics 118 (2006) 698-703
16. Elder J., Diaz M., and Caldamone A.A. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175 (2003) 716-722
17. Capozza N., Lais A., Matarazzo E., Nappo S., Patricolo M., and Caione P. Influence of voiding dysfunction on the outcome of endoscopic treatment for vesicoureteral reflux. J Urol 168 4 Pt 2 (2002 Oct) 1695-1698
18. Capozza N., Lais A., Nappo S., and Caione P. The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience. J Urol 172 (2004) 1626-1629
19. Lackgren G., Skoldenberg E., and Stenberg A. Endoscopic treatment with stabilized nonanimal hyaluronic acid/dextranomer gel is effective in vesicoureteral reflux associated with bladder dysfunction. J Urol 177 (2007) 1124-1129
20. Perez-Brayfield M., Kirsch A.J., Hensle T.W., Koyle M.A., Furness P., and Scherz H.C. Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux. J Urol 172 (2004) 1614-1616
21. Elder J.S., Peters C.A., Arant B.S., et al. Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J Urol 157 (1997) 1846-1851
22. Cerwinka W.H., Scherz H.C., and Kirsch A.J. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children. J Urol 178 (2007) 1469-1473
23. Kitchens D., Minevich E., DeFoor W., Reddy P., Wacksman J., Sheldon C., et al. Endoscopic injection of dextranomer/hyaluronic acid copolymer to correct vesicoureteral reflux following failed ureteroneocystostomy. J Urol 176 (2006) 1861-1863
24. Jung C., DeMarco R.T., Lowrance W.T., Pope J.C., Adams M.C., Dietrich M.S., et al. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy. J Urol 177 (2007) 312-315
25. Kumar R., and Puri P. Newly diagnosed contralateral reflux after successful unilateral endoscopic correction: is it due to the pop-off mechanism?. J Urol 158 (1997) 1213-1215
26. Williams D.I. Vesico-ureteric reflux. In: Williams D.I., Barratt T.M., Eckstein H.B., Kohlinsky S.M., Newns G.H., Polani P.E., et al. (Eds). Urology in childhood (1974), Springer-Verlag, New York 111-136
27. Diamond D.A., Rabinowitz R., Hoenig D.M., and Caldamone A.A. The mechanism of new onset contralateral reflux following unilateral ureteroneocystostomy. J Urol 156 (1996) 665
28. Noe H.N. The risk and risk factors of contralateral reflux following repair of simple unilateral primary reflux. J Urol 160 (1998) 849-850
29. Elmore J.M., Kirsch A.J., Lyles R.H., Perez-Brayfield M.R., and Scherz H.C. New contralateral vesicoureteral reflux following dextranomer/hyaluronic acid implantation: incidence and identification of a high risk group. J Urol 175 (2006) 1097-1101
30. Kirsch AJ, Elmore JM, Lyles RH, Scherz HC. Dynamic hydrodistention classification of the ureteral orifice is predictive of the severity of vesicoureteral reflux and correlates with the presence of febrile urinary tract infections. American Urological Association Annual Meeting, 20-25 May 2006, Atlanta, Georgia [abstract 758].
31. Wheeler D.M., Vimalachandra D., Hodson E.M., Smith G.H., and Craig J.C. Interventions for primary vesicoureteral reflux. Cochrane Database Syst Rev 3 (2004) CD001532
32. Lavelle M., and Skoog S. Subureteral injection of deflux for correction of reflux: analysis of factors predicting success. Urology 65 (2005) 564-567
33. Yucel S., Gupta A., and Snodgrass W. Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 177 (2007) 1505-1509
34. Higham-Kessler J., Reinert S.E., Snodgrass W.T., et al. A review of failures of endoscopic treatment of vesicoureteral reflux with dextranomer microspheres. J Urol 177 (2007) 710-715
35. Elmore J.M., Scherz H.C., and Kirsch A.J. Dextranomer/hyaluronic acid for vesicoureteral reflux: success rates after initial treatment failure. J Urol 175 (2006) 712-715
36. Elmore J.M., Kirsch A.J., Perez-Brayfield M.R., Scherz H.C., and Koyle M.A. Salvage extravesical ureteral reimplantation after failed endoscopic surgery for vesicoureteral reflux. J Urol 176 (2006) 1158-1160
37. McMann L.P., Scherz H.C., and Kirsch A.J. Long-term preservation of dextranomer/hyaluronic acid copolymer implants after endoscopic treatment of vesicoureteral reflux in children: a sonographic volumetric analysis. J Urol 177 (2007) 316-320
38. Molitierno Jr JA, Scherz HC, Kirsch AJ. Endoscopic Injection of dextranomer hyaluronic acid copolymer for the treatment of vesicoureteral reflux in duplex ureters. J Pediatr Urol, doi:10.1016/j.jpurol.2008.01.216.
39. Elmore J.M., Kirsch A.J., Heiss E.A., Gilchrist A., and Scherz H.C. Incidence of Urinary Tract Infections in children after successful ureteral reimplantation versus endoscopic the dentranomer/hyaluronic acid implantation. J Urol 179 6 (2008) 2364-2368